Audible. Only £0.99 a month for the first 3 months. Auto-renews at £7.99/mo, after 3 months. Ends January 21, 2025. Start my membership

19. Verbesserte Ergebnisse mit Enzalutamid bei biochemisch rezidivierendem Prostatakrebs
Mar 19 2024
Length: 22 mins
Podcast

Failed to add items

Sorry, we are unable to add the item because your shopping cart is already at capacity.

Add to basket failed.

Please try again later

Add to wishlist failed.

Please try again later

Remove from wishlist failed.

Please try again later

Adding to library failed

Please try again

Follow podcast failed

Unfollow podcast failed

19. Verbesserte Ergebnisse mit Enzalutamid bei biochemisch rezidivierendem Prostatakrebs

Listen for free

View show details

Summary
In dieser Folge haben wir für Sie die Studie „Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer.“ ausgewählt.

Show More Show Less

Show More Show Less

What listeners say about 19. Verbesserte Ergebnisse mit Enzalutamid bei biochemisch rezidivierendem Prostatakrebs

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.co.uk reviews

Amazon reviews

No Reviews are Available

Report a review on Amazon